The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHD
NCT02267200 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2016-11-22
Summary
The purpose of this study is to analyse the sensitivity and specificity of circulating endothelial cells to predict irreversible pulmonary arterial hypertension associated with congenital heart disease.
Conditions
- Hypertension,Pulmonary
Sponsors & Collaborators
-
Shanghai Jiao Tong University School of Medicine
lead OTHER
Principal Investigators
-
Zhuoming Xu, Ph D · Shanghai Jiao Tong University School of Medicine
Eligibility
- Min Age
- 1 Month
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2016-09-30
- Completion
- 2016-09-30
Countries
- China
Study Locations
More Related Trials
-
Clinical Characteristics of Acute Pulmonary Embolism in Chinese Population
NCT02214043 ·Status: COMPLETED
-
Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term Outcome
NCT02565030 ·Status: COMPLETED
-
The Mechanism and Prognosis of Pulmonary Circulation Dysfunction
NCT03616366 ·Status: UNKNOWN
-
Multi-marker Approach for Risk Assessment in PAH
NCT03954405 ·Status: RECRUITING
-
Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies
NCT02959723 ·Status: UNKNOWN
-
Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography
NCT05482269 ·Status: RECRUITING
-
Thrombolytic and Interventional Treatment of Pulmonary Embolism
NCT03886194 ·Status: UNKNOWN ·Phase: NA
-
The Study Of CT Scans and Echo Parameters in Patients With PAH
NCT00625963 ·Status: COMPLETED
-
A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.
NCT05098769 ·Status: RECRUITING
-
Pulmonary Embolism Prognosis Model
NCT04411888 ·Status: UNKNOWN
-
Prevalence and Risk Factors of Pulmonary Hypertension in Patients with Myeloproliferative Neoplasms in Assiut University Hospital.
NCT06647706 ·Status: NOT_YET_RECRUITING
-
Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans
NCT00621075 ·Status: COMPLETED
-
Prospective Validation of an Acute Pulmonary Embolism Severity and Prognosis Prediction Model
NCT05723003 ·Status: RECRUITING
-
Pulmonary Embolism: Mechanism and Therapeutic Innovation
NCT05360992 ·Status: COMPLETED
-
Screening of Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers
NCT01600898 ·Status: COMPLETED
-
Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension
NCT01572077 ·Status: COMPLETED ·Phase: NA
-
Right Ventricular Metabolism in Pulmonary Arterial Hypertension
NCT02763735 ·Status: COMPLETED
-
Non-Invasive Measurement of Cardiac Output and Stroke Volume in PAH/CTEPH
NCT05618093 ·Status: WITHDRAWN ·Phase: NA
-
The Diagnostic Value of APTT/Fibrinogen Ratio in Pulmonary Embolism
NCT06192199 ·Status: RECRUITING
-
Endothelial Cell Dysfunction in Pulmonary Hypertension
NCT00098072 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Blood Coagulation Disorders in Patients With Pulmonary Hypertension
NCT03195543 ·Status: UNKNOWN
-
Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH)
NCT03819777 ·Status: UNKNOWN
-
Identification of Criteria of the Success of the Endarterectomy in Chronic Pulmonary Post Embolic Hypertension
NCT00657722 ·Status: COMPLETED ·Phase: NA
-
Exploring Blood Cell Function and Oxidative Stress to Improve Diagnosis and Treatment in Pre-Capillary Pulmonary Hypertension
NCT07176260 ·Status: RECRUITING
-
Clinical, Radiological, Tissue and Biological Phenotyping for the Analysis of the Transition From Physiology to Pathology in Pulmonary Diseases With Pulmonary Hypertension
NCT07184671 ·Status: NOT_YET_RECRUITING